Al-Ahmad M, Webb D. A prospective study of switching asthma patients from a Fixed-Dose Combination
(FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy
delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised
Metered Dose Inhaler ( Respir Med 2022;194:106771.
PMID: 35180515